We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+9.07%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
AUM
$1.59B
AUM Growth
-$123M
Cap. Flow
-$210M
Cap. Flow %
-13.19%
Top 10 Hldgs %
37.97%
Holding
82
New
22
Increased
19
Reduced
11
Closed
19

Sector Composition

Rank Sector Weight
1 Healthcare 18.49%
2 Financials 17.56%
3 Industrials 12.41%
4 Consumer Discretionary 10.65%
5 Technology 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LORL
26
DELISTED
Loral Space and Communications, Inc.
LORL
$27.6M 1.74%
710,175
+112,329
+19% +$4.27M
BPOP icon
27
Popular Inc
BPOP
$11.2B
$27.3M 1.72%
363,954
-61,881
-15% -$4.74M
OMF icon
28
OneMain Financial
OMF
$7.32B
$24.5M 1.54%
409,183
-180,817
-31% -$10.2M
FBP icon
29
First Bancorp
FBP
$4.43B
$23.5M 1.48%
1,973,369
-390,234
-17% -$4.81M
COOP
30
DELISTED
Mr. Cooper
COOP
$21M 1.32%
636,221
-26,502
-4% -$885K
RDN icon
31
Radian Group
RDN
$4.86B
$20.9M 1.31%
938,368
MX icon
32
Magnachip Semiconductor
MX
$142M
$20.8M 1.31%
872,308
-1,098,947
-56% -$26.9M
MTG icon
33
MGIC Investment
MTG
$6.23B
$20.7M 1.3%
1,521,006
SC
34
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$19.9M 1.25%
547,946
-1,013,649
-65% -$35.2M
ADV icon
35
Advantage Solutions
ADV
$387M
$18.2M 1.15%
67,542
NVRI icon
36
Enviri
NVRI
$566M
$18.2M 1.14%
+889,708
New +$18.3M
MREO
37
Mereo BioPharma
MREO
$48.8M
$17.9M 1.13%
5,660,608
+2,745,747
+94% +$9.21M
MORF
38
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$17.5M 1.1%
304,410
+215,363
+242% +$11.8M
RDUS
39
DELISTED
Radius Health, Inc.
RDUS
$17.3M 1.09%
947,163
+498,348
+111% +$9.91M
HY icon
40
Hyster-Yale Materials Handling
HY
$619M
$16.2M 1.02%
221,514
GSM icon
41
FerroAtlántica
GSM
$854M
$12.2M 0.77%
+2,000,000
New +$9.34M
SIOX
42
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$8.19M 0.52%
3,000,000
+499,582
+20% +$1.24M
SBBP
43
DELISTED
Strongbridge Biopharma plc.
SBBP
$8.01M 0.5%
+2,695,764
New +$7.12M
VINC
44
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$6.93M 0.44%
+26,683
New +$8.13M
QSI icon
45
Quantum-Si Incorporated
QSI
$179M
$6.04M 0.38%
+493,013
New +$5.16M
LSAK icon
46
Lesaka Technologies
LSAK
$414M
$5.43M 0.34%
1,151,941
-980,681
-46% -$5.11M
MARA icon
47
Marathon Digital Holdings
MARA
$3.74B
$4.99M 0.31%
+159,134
New +$5.05M
KURA icon
48
Kura Oncology
KURA
$882M
$4.83M 0.3%
+231,481
New +$5.75M
KDNY
49
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$4.6M 0.29%
325,863
SOFI icon
50
PUT
SoFi Technologies
SOFI
$23.2B
$3.69M 0.23%
+192,500
New +$3.57M

Similar funds

Rubric Capital Management (New York)'s Q2 2021 Portfolio in Review

As of Q2 2021, Rubric Capital Management (New York) held 82 positions worth $1.59B, down 7.2% from $1.71B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Rubric Capital Management (New York) withdrew a net $210M in Q2 2021, closing 19 positions and reducing 11 holdings. Its most notable exit was Rackspace Technology, an estimated $54.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 10% a quarter earlier, followed by Financials and Industrials.

Against the trend, Rubric Capital Management (New York) opened a new position in Golar LNG worth $69.6M.

  • Rubric Capital Management (New York)'s largest Q2 2021 buy was Golar LNG: 5,255,268 shares worth $69.6M.
  • Rubric Capital Management (New York) added most to Ocular Therapeutix in Q2 2021, an estimated $27M increase.
  • Rubric Capital Management (New York)'s biggest Q2 2021 reduction was InterDigital, cutting an estimated $40.9M.
  • Rubric Capital Management (New York) fully exited Rackspace Technology in Q2 2021, selling an estimated $54.7M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 38% of its $1.59B portfolio in Q2 2021.
  • Rubric Capital Management (New York) opened 22 new positions and closed 19 in Q2 2021.
  • Rubric Capital Management (New York)'s portfolio value fell 7.2% quarter-over-quarter to $1.59B.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2021, filed 13 Aug 2021.